Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Ling, Lin"'
Autor:
Hung-Yu Lin, Pei-Lin Liao, Jiin-Haur Chuang, Li Ling Lin, Wen-Ming Hsu, Chao-Cheng Huang, Hui-Ching Chuang
Publikováno v:
Laboratory Investigation. 100:606-618
High-risk neuroblastoma is associated with low long-term survival rates due to recurrence or metastasis. Retinoids, including 13-cis-retinoic acid (13cRA), are commonly used for the treatment of high-risk neuroblastoma after myeloablative therapy; ho
Autor:
Mingyi Li, Fang Yang, Ling Lin, Zhi-Rui Lin, Wen-Jing Yin, Yi Yu, Yan-Yi Zhu, Liu Jinquan, Bin Qi, Li Zhouyu, Lu He, Meng-Yao Wang, Dong-Ping Chen
Publikováno v:
Cell Death and Disease, Vol 10, Iss 6, Pp 1-12 (2019)
Cell Death & Disease
Cell Death & Disease
Accumulating evidence has indicated crucial roles for pseudogenes in human cancers. However, the roles played by pseudogenes in the pathogenesis of HCC, particularly HCC early recurrence, still incompletely elucidated. Herein, we identify a novel ear
Publikováno v:
Cancer Management and Research
Qing Cong,1,2,* Ling Lin,1,3,* Biao Qi,4 Congjian Xu,1,2 Xiaoyan Zhang1,2 1Obstetrics and Gynecology Hospital, Fudan University, Shanghai, People’s Republic of China; 2Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Shang
Publikováno v:
Tissuecell. 72
LINC01089, a newly discovered long non-coding RNA (lncRNA), has been reported to inhibit the progression of various types of cancers. This study aimed to characterize LINC01089 in the pathogenesis of lung adenocarcinoma (LUAD). LINC01089 expression i
Publikováno v:
The American journal of pathology. 191(10)
Human papillomavirus (HPV) is a ubiquitous human pathogen that can be cleared by host immunity. Nonetheless, a small percentage of the patients develop persistent infection with oncogenic HPV, which poses an increased risk of developing HPV-associate
Publikováno v:
Journal of cellular physiologyREFERENCES. 236(7)
Cervical cancer (CC) has caused numerous cancer-related deaths in women. Recent years, circular RNAs have been reported as vital factors in CC tumorigenesis. Our current study focused on the role of hsa_circ_0102171 (called circ_0102171 subsequently)
Autor:
Jeff Yi-Fu Chen, Chih-Chang Hung, Shih-Shin Liang, Chiu-Hsien Lee, Ling-Feng Wang, Fu An Li, Chien-Chih Chiu, I-Ling Lin
Publikováno v:
Molecules
Volume 25
Issue 17
Molecules, Vol 25, Iss 3815, p 3815 (2020)
Volume 25
Issue 17
Molecules, Vol 25, Iss 3815, p 3815 (2020)
Prolonged treatment with cisplatin (CDDP) frequently develops chemoresistance. We have previously shown that p22phox, an endoplasmic reticulum (ER) membrane protein, confers CDDP resistance by blocking CDDP nuclear entry in oral squamous cell carcino
Autor:
Ling Lin, Jianhua Cai
Publikováno v:
Journal of cellular biochemistryREFERENCES. 121(11)
Renal cell carcinoma (RCC) is a highly lethal cancer with increasing incidence worldwide. The purpose of the present study was to investigate the functions and molecular mechanisms of circular RNA (circRNA), circ-EGLN3, in RCC progression. The expres
Autor:
Lu He, Liu Jinquan, Ming-Yi Li, Meng-Yao Wang, Ling Lin, Dong-Ping Chen, Yi Yu, Wen-Jin Yin, Bin Qi, Li Zhouyu
Publikováno v:
Cancer Biology & Therapy. 18:681-693
Nasopharyngeal carcinoma (NPC) is a common malignant neoplasm of the head and neck which is harmful to human's health. Radiotherapy is commonly used in the treatment of NPC and it induces immediate cell cycle arrest and cell apoptosis. However, the m
Autor:
Shu-Pin Huang, Wei-Chung Cheng, Fang-Yen Chiu, Po Len Liu, Hsin Chih Yeh, Shih-Hua Fang, Ming-Yii Huang, Chia Cheng Su, Chia-Yang Li, I-Ling Lin, Kun-Lin Hsieh, Kuan-Hua Huang
Publikováno v:
International Journal of Molecular Sciences
Volume 20
Issue 7
International Journal of Molecular Sciences, Vol 20, Iss 7, p 1647 (2019)
Volume 20
Issue 7
International Journal of Molecular Sciences, Vol 20, Iss 7, p 1647 (2019)
Current clinical challenges of prostate cancer management are to restrict tumor growth and prohibit metastasis. AICAR (5-aminoimidazole-4-carbox-amide-1-&beta
d-ribofuranoside), an AMP-activated protein kinase (AMPK) agonist, has demonstrated an
d-ribofuranoside), an AMP-activated protein kinase (AMPK) agonist, has demonstrated an